Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

De Novo Assembly of a High-Quality Reference Genome for the Horned Lark (Eremophila alpestris).

Mason NA, Pulgarin P, Cadena CD, Lovette IJ.

G3 (Bethesda). 2020 Feb 6;10(2):475-478. doi: 10.1534/g3.119.400846.

2.

Impact of a Pharmacy Student Organization on the Admissions Experience and Student Professional Development.

Kwiatkowski S, Klein KC, Mason NA.

Am J Pharm Educ. 2019 Sep;83(7):7178. doi: 10.5688/ajpe7178.

3.

Evaluation of peer-led study groups in a PharmD program.

Varshney N, Mason NA.

Curr Pharm Teach Learn. 2019 May;11(5):485-491. doi: 10.1016/j.cptl.2019.02.005. Epub 2019 May 10.

PMID:
31171250
4.

Assessment of mental health in doctor of pharmacy students.

Sabourin AA, Prater JC, Mason NA.

Curr Pharm Teach Learn. 2019 Mar;11(3):243-250. doi: 10.1016/j.cptl.2018.12.004. Epub 2018 Dec 28.

PMID:
30904145
5.

Hidden endemism, deep polyphyly, and repeated dispersal across the Isthmus of Tehuantepec: Diversification of the White-collared Seedeater complex (Thraupidae: Sporophila torqueola).

Mason NA, Olvera-Vital A, Lovette IJ, Navarro-Sigüenza AG.

Ecol Evol. 2018 Jan 12;8(3):1867-1881. doi: 10.1002/ece3.3799. eCollection 2018 Feb.

6.

Contrasting impacts of competition on ecological and social trait evolution in songbirds.

Drury JP, Tobias JA, Burns KJ, Mason NA, Shultz AJ, Morlon H.

PLoS Biol. 2018 Jan 31;16(1):e2003563. doi: 10.1371/journal.pbio.2003563. eCollection 2018 Jan.

7.

Song evolution, speciation, and vocal learning in passerine birds.

Mason NA, Burns KJ, Tobias JA, Claramunt S, Seddon N, Derryberry EP.

Evolution. 2017 Mar;71(3):786-796. doi: 10.1111/evo.13159. Epub 2017 Jan 9.

8.

Evolutionary innovation and diversification of carotenoid-based pigmentation in finches.

Ligon RA, Simpson RK, Mason NA, Hill GE, McGraw KJ.

Evolution. 2016 Dec;70(12):2839-2852. doi: 10.1111/evo.13093. Epub 2016 Nov 7.

PMID:
27757952
9.

Phenotypes in phylogeography: Species' traits, environmental variation, and vertebrate diversification.

Zamudio KR, Bell RC, Mason NA.

Proc Natl Acad Sci U S A. 2016 Jul 19;113(29):8041-8. doi: 10.1073/pnas.1602237113. Review.

10.

A genus-level classification of the family Thraupidae (Class Aves: Order Passeriformes).

Burns KJ, Unitt P, Mason NA.

Zootaxa. 2016 Mar 9;4088(3):329-54. doi: 10.11646/zootaxa.4088.3.2.

PMID:
27394344
11.

Analysis of Medications Returned During a Medication Take-Back Event.

Yang CHJ, Doshi M, Mason NA.

Pharmacy (Basel). 2015 Jul 27;3(3):79-88. doi: 10.3390/pharmacy3030079.

12.
13.

Differentially expressed genes match bill morphology and plumage despite largely undifferentiated genomes in a Holarctic songbird.

Mason NA, Taylor SA.

Mol Ecol. 2015 Jun;24(12):3009-25. doi: 10.1111/mec.13140. Epub 2015 Mar 30.

PMID:
25735539
14.

Elaborate visual and acoustic signals evolve independently in a large, phenotypically diverse radiation of songbirds.

Mason NA, Shultz AJ, Burns KJ.

Proc Biol Sci. 2014 Aug 7;281(1788):20140967. doi: 10.1098/rspb.2014.0967.

15.

Phylogenetics and diversification of tanagers (Passeriformes: Thraupidae), the largest radiation of Neotropical songbirds.

Burns KJ, Shultz AJ, Title PO, Mason NA, Barker FK, Klicka J, Lanyon SM, Lovette IJ.

Mol Phylogenet Evol. 2014 Jun;75:41-77. doi: 10.1016/j.ympev.2014.02.006. Epub 2014 Feb 26.

PMID:
24583021
16.

Polypharmacy and medication-related complications in the chronic kidney disease patient.

Mason NA.

Curr Opin Nephrol Hypertens. 2011 Sep;20(5):492-7. doi: 10.1097/MNH.0b013e328349c261. Review.

PMID:
21788893
17.

Improving student education and patient care through an innovative introductory pharmacy practice experience.

Walker PC, Kinsey KS, Kraft MD, Mason NA, Clark JS.

Am J Health Syst Pharm. 2011 Apr 15;68(8):655, 658, 660. doi: 10.2146/ajhp100490. No abstract available.

PMID:
21460170
18.

An advanced pharmacy practice experience in transitional care.

Walker PC, Tucker Jones JN, Mason NA.

Am J Pharm Educ. 2010 Mar 10;74(2):20.

19.

Safety and tolerability of intravenous ferric carboxymaltose in patients with iron deficiency anemia.

Bailie GR, Mason NA, Valaoras TG.

Hemodial Int. 2010 Jan;14(1):47-54. doi: 10.1111/j.1542-4758.2009.00409.x. Epub 2009 Nov 3.

20.

Strategies for reducing polypharmacy and other medication-related problems in chronic kidney disease.

Mason NA, Bakus JL.

Semin Dial. 2010 Jan-Feb;23(1):55-61. doi: 10.1111/j.1525-139X.2009.00629.x. Epub 2009 Sep 11.

21.

Prescription of antihypertensive agents to haemodialysis patients: time trends and associations with patient characteristics, country and survival in the DOPPS.

Lopes AA, Bragg-Gresham JL, Ramirez SP, Andreucci VE, Akiba T, Saito A, Jacobson SH, Robinson BM, Port FK, Mason NA, Young EW.

Nephrol Dial Transplant. 2009 Sep;24(9):2809-16. doi: 10.1093/ndt/gfp212. Epub 2009 May 14.

PMID:
19443648
22.

Diuretic use, residual renal function, and mortality among hemodialysis patients in the Dialysis Outcomes and Practice Pattern Study (DOPPS).

Bragg-Gresham JL, Fissell RB, Mason NA, Bailie GR, Gillespie BW, Wizemann V, Cruz JM, Akiba T, Kurokawa K, Ramirez S, Young EW.

Am J Kidney Dis. 2007 Mar;49(3):426-31.

PMID:
17336704
23.

Sexual dysfunction in dialysis patients treated with antihypertensive or antidepressive medications: results from the DOPPS.

Bailie GR, Elder SJ, Mason NA, Asano Y, Cruz JM, Fukuhara S, Lopes AA, Mapes DL, Mendelssohn DC, Bommer J, Young EW.

Nephrol Dial Transplant. 2007 Apr;22(4):1163-70. Epub 2007 Feb 1.

PMID:
17284436
24.

Large variations in prescriptions of gastrointestinal medications in hemodialysis patients on three continents: the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Bailie GR, Mason NA, Elder SJ, Andreucci VE, Greenwood RN, Akiba T, Saito A, Bragg-Gresham JL, Gillespie BW, Young EW.

Hemodial Int. 2006 Apr;10(2):180-8.

25.

Analysis of medication use in peritoneal dialysis patients in two units.

Bailie GR, Mason NA, Elwell RJ, Sy FZ.

Perit Dial Int. 2005 May-Jun;25(3):287-90. No abstract available.

PMID:
15981778
26.

HMG-coenzyme a reductase inhibitor use is associated with mortality reduction in hemodialysis patients.

Mason NA, Bailie GR, Satayathum S, Bragg-Gresham JL, Akiba T, Akizawa T, Combe C, Rayner HC, Saito A, Gillespie BW, Young EW.

Am J Kidney Dis. 2005 Jan;45(1):119-26.

PMID:
15696451
27.

Screening for depression in hemodialysis patients: associations with diagnosis, treatment, and outcomes in the DOPPS.

Lopes AA, Albert JM, Young EW, Satayathum S, Pisoni RL, Andreucci VE, Mapes DL, Mason NA, Fukuhara S, Wikström B, Saito A, Port FK.

Kidney Int. 2004 Nov;66(5):2047-53. Erratum in: Kidney Int. 2004 Dec;66(6):2486.

28.

Analgesic prescription patterns among hemodialysis patients in the DOPPS: potential for underprescription.

Bailie GR, Mason NA, Bragg-Gresham JL, Gillespie BW, Young EW.

Kidney Int. 2004 Jun;65(6):2419-25.

29.
30.

Beneficial effects of phosphodiesterase 5 inhibition in pulmonary hypertension are influenced by natriuretic Peptide activity.

Zhao L, Mason NA, Strange JW, Walker H, Wilkins MR.

Circulation. 2003 Jan 21;107(2):234-7.

PMID:
12538421
31.

Sildenafil inhibits hypoxia-induced pulmonary hypertension.

Zhao L, Mason NA, Morrell NW, Kojonazarov B, Sadykov A, Maripov A, Mirrakhimov MM, Aldashev A, Wilkins MR.

Circulation. 2001 Jul 24;104(4):424-8.

PMID:
11468204
32.

Methicillin resistance patterns associated with peritonitis in a university-based peritoneal dialysis center.

Mason NA, Zhang T, Messana JM.

Perit Dial Int. 1999 Sep-Oct;19(5):483-6. No abstract available.

PMID:
11379864
33.

Characterization of adenylyl cyclase isoforms in rat peripheral pulmonary arteries.

Jourdan KB, Mason NA, Long L, Philips PG, Wilkins MR, Morrell NW.

Am J Physiol Lung Cell Mol Physiol. 2001 Jun;280(6):L1359-69.

34.

Intravenous iron products.

Johnson CA, Mason NA, Bailie GR.

Nephrol Nurs J. 2000 Feb;27(1):66. No abstract available.

PMID:
10852694
35.

Intravenous iron products.

Johnson CA, Mason NA, Bailie GR.

ANNA J. 1999 Oct;26(5):522-4. Review.

PMID:
10776081
36.

Parenteral iron use in the management of anemia in end-stage renal disease patients.

Bailie GR, Johnson CA, Mason NA.

Am J Kidney Dis. 2000 Jan;35(1):1-12. Review.

PMID:
10620537
37.

Trainees' activities and experiences after a clinical pharmacy dialysis traineeship.

Mason NA, St Peter WM, Johnson CA, Bailie GR.

Am J Health Syst Pharm. 1999 Aug 15;56(16):1623-6. No abstract available.

PMID:
10459383
38.

High expression of endothelial nitric oxide synthase in plexiform lesions of pulmonary hypertension.

Mason NA, Springall DR, Burke M, Pollock J, Mikhail G, Yacoub MH, Polak JM.

J Pathol. 1998 Jul;185(3):313-8.

PMID:
9771486
39.

Expression of inducible nitric oxide synthase and formation of peroxynitrite in posttransplant obliterative bronchiolitis.

Mason NA, Springall DR, Pomerance A, Evans TJ, Yacoub MH, Polak JM.

J Heart Lung Transplant. 1998 Jul;17(7):710-4.

PMID:
9703237
40.

Human lung mononuclear cells induce nitric oxide synthase in murine airway epithelial cells in vitro: role of TNFalpha and IL-1beta.

Robbins RA, Sisson JH, Springall DR, Nelson KJ, Taylor JA, Mason NA, Polak JM, Townley RG.

Am J Respir Crit Care Med. 1997 Jan;155(1):268-73.

PMID:
9001323
41.

Calcitriol in the management of secondary hyperparathyroidism of renal failure.

Daisley-Kydd RE, Mason NA.

Pharmacotherapy. 1996 Jul-Aug;16(4):619-30. Review.

42.

Influence of cellulose triacetate hemodialyzers on vancomycin pharmacokinetics.

Welage LS, Mason NA, Hoffman EJ, Odeh RM, Dombrouski J, Patel JA, Swartz RD.

J Am Soc Nephrol. 1995 Oct;6(4):1284-90.

43.

Pharmacist participation in cardiopulmonary resuscitation.

Shimp LA, Mason NA, Toedter NM, Atwater CB, Gorenflow DW.

Am J Health Syst Pharm. 1995 May 1;52(9):980-4.

PMID:
7641036
44.

Update on erythropoietin.

Mason NA.

Am Pharm. 1994 Sep;NS34(9):16-8. No abstract available.

PMID:
7977020
45.

Benefits and work-schedule options for female hospital pharmacists.

Mason NA, Gaither CA, Hoffman EJ, Diokno DA.

Am J Hosp Pharm. 1994 Mar 15;51(6):790-7.

PMID:
8010318
46.

Benefits and work-schedule options in hospital pharmacy practice.

Gaither CA, Mason NA, Diokno DA, Hoffman EJ.

Am J Hosp Pharm. 1994 Mar 15;51(6):782-9.

PMID:
8010317
47.
48.

Chronic hemodialysis patients. Part I: Characterization and drug-related problems.

Kaplan B, Mason NA, Shimp LA, Ascione FJ.

Ann Pharmacother. 1994 Mar;28(3):316-9.

PMID:
8193416
49.

Drug usage evaluation of epoetin in chronic renal failure.

Mason NA, Iacobellis DP.

Hosp Formul. 1992 Sep;27(9):928-32, 937-8.

PMID:
10121421
50.

Consumer vinegar test for determining calcium disintegration.

Mason NA, Patel JD, Dressman JB, Shimp LA.

Am J Hosp Pharm. 1992 Sep;49(9):2218-22.

PMID:
1524066

Supplemental Content

Loading ...
Support Center